RRML - The role of qSOFA score and biomarkers in assessing severity of community-acquired pneumonia in adults
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- May 2021 -
 
Prognostic value of serum lact... 15
Romanian Review of Laboratory ... 8
Pseudohyponatremia and falsely... 8
Vaginal candidiasis in Konya a... 7
The possibility of clinical us... 7
Evaluation of Plasma AA/DHA+EP... 6
Prevalence of ∆F508 cystic f... 6
Predictors associated with inc... 6
Reliability of Friedewald form... 5
Frequency, Distribution and Ge... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 29(1)/2021 DOI:10.2478/rrlm-2020-0038
XML
TXT

Research article

The role of qSOFA score and biomarkers in assessing severity of community-acquired pneumonia in adults

Raluca-Elena Tripon, Victor Cristea, Mihaela-Sorina Lupse

Correspondence should be addressed to: Raluca-Elena Tripon

Abstract:

Introduction: Community-acquired pneumonia (CAP) is the primary cause of severe sepsis. Severity assessment scores have been created, in order to help physicians decide the proper management of CAP. The purpose of this study was to examine the correlations between different CAP severity scores, including qSOFA, several biomarkers and their predictive value in the 30 day follow-up period, regarding adverse outcome. Materials and methods: One hundred and thirty nine adult patients with CAP, admitted in the Teaching Hospital of Infectious Diseases, Cluj-Napoca, Romania from December 2015 to February 2017, were enrolled in this study. Pneumonia Severity Index (PSI), CURB-65, SMART-COP and the qSOFA scores were calculated at admittance. Also, C-reactive protein (CRP), procalcitonin (PCT) and albumin levels were used to determine severity. Results: The mean PSI of all patients was 93.30±41.135 points, for CURB-65 it was 1.91±0.928 points, for SMART-COP it was 1.69±1.937 points. The mean qSOFA was 1.06±0.522 points, 21 (14.9%) were at high risk of in-hospital mortality. In the group of patients with qSOFA of ≥2, all pneumonia severity scores and all biomarkers tested were higher than those with scores <2. We found significant correlations between biomarkers and severity scores, but none regarding adverse outcome. Conclusion: The qSOFA score is easier to use and it is able to accurately evaluate the severity of CAP, similar to other scores. Biomarkers are useful in determining the severity of the CAP. Several studies are needed to assess the prediction of these biomarkers and severity scores in pneumonia regarding adverse outcome.

Keywords: biomarkers, albumin, community-acquired pneumonia, qSOFA, pneumonia severity scores

Received: 3.7.2020
Accepted: 1.11.2020
Published: 2.1.2021

 
  PDF Download full text PDF
(468 KB)
     
 
How to cite
Tripon RE, Cristea V, Lupse MS. The role of qSOFA score and biomarkers in assessing severity of community-acquired pneumonia in adults. Rev Romana Med Lab. 2021;29(1):65-75. DOI:10.2478/rrlm-2020-0038